Shields Matthew

Track

Insider profile

Shields Matthew's trades of Teva Pharmaceutical Industries Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18
S Sale
1,311 +41.7%
224.28
US$263,385 		1,311 +41.7% 224.28 US$263,385
2026-06-22 2026-06-18
S Sale
43,212 +47.6%
183.88
US$3,918,070 		43,212 +47.6% 183.88 US$3,918,070
2026-06-18 2026-06-18
PrS Proposed sale
83,865
347.68
US$4,878,473 		83,865 347.68 US$4,878,473
2026-06-04 2026-06-03
PlS Planned sale
16,195 -61.9%
32.87
US$532,330 		16,195 -61.9% 32.87 US$532,330
2026-06-03 2026-06-03
PrS Proposed sale
16,195
32.87
US$532,330 		16,195 32.87 US$532,330
2026-03-09 2026-03-05
PlS Planned sale
17,295 -63.4%
31.67
US$547,705 		17,295 -63.4% 31.67 US$547,705
2026-03-05 2026-03-05
PrS Proposed sale
17,295
31.67
US$547,705 		17,295 31.67 US$547,705
2025-06-05 2025-06-03
S Sale
6,206 -38.3%
17.02
US$105,628 		6,206 -38.3% 17.02 US$105,628
2025-06-03 2025-06-03
PrS Proposed sale
6,206
17.02
US$105,628 		6,206 17.02 US$105,628